CareCloud, Inc. (CCLD) Stock Forecast & Price Target
CareCloud, Inc. · NASDAQ
$2.18-0.05 (-2.24%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering CareCloud, Inc, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $3.25 to $3.25, so the covering firms are broadly aligned. The average target of $3.25 sits 49% above the current $2.18. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.11 next quarter toward $0.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to CareCloud, Inc.
As of Sep, 0 of 1 firms rate CCLD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CCLD EPS & revenue forecast
EPS · NEXT QUARTER
$0.11
Range $0.09 – $0.12 · 3 analysts · +167% YoY
Next period, 3 analysts expect CareCloud, Inc. to earn $0.11 a share (range $0.09 – $0.12), versus $0.04 a year earlier. Full-year consensus is $0.37, growing to $0.30 the year after.
REVENUE · NEXT QUARTER
$33.8M
Range $32.6M – $35.0M · 3 analysts · -2% YoY
Revenue is expected to reach $33.8M (range $32.6M – $35.0M), -1.8% year-over-year. Full-year consensus is $130.3M, rising to $141.2M next year.
Top analysts covering CareCloud, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CCLD.
#1
BS
Bill Sutherland
Benchmark · Rank #45
Buy
$4.50+106.4% to target
Overall win rate
45%
+ Follow
#2
Richard Baldry
Roth MKM · Rank #356
Hold
$2.50+14.7% to target
Overall win rate
30%
+ Follow
#3
Ashok Kumar
ThinkEquity
Buy
$8.00+267.0% to target
Coverage
—
+ Follow
CCLD stock forecast FAQ
What is CCLD's average 12-month price target?+
The 1 analysts with a live target average $3.25 for CareCloud, Inc. over the next 12 months, ranging from a $3.25 high to a $3.25 low.
Is CCLD stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CCLD?+
1 analysts have an active rating on CareCloud, Inc., and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CCLD?+
Among analysts who currently cover CCLD, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #45). Their current call is Buy with a $4.50 target.
What is CareCloud, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.11 per share (range $0.09 – $0.12) across 3 analysts. Full-year EPS is projected at $0.37, rising to $0.30 the following year.
How much revenue is CareCloud, Inc. expected to report next quarter?+
Consensus revenue is $33.8M (range $32.6M – $35.0M). Full-year revenue is projected at $130.3M, growing to $141.2M next year.
Have analysts been upgrading or downgrading CCLD lately?+
As of Sep, 0 of 1 firms rate CCLD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CCLD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
